Dave Lowrance
2018
Compensation breakdown
Non-Equity Incentive Plan | $116,891 |
---|---|
Option Awards | $1,671,362 |
Salary | $365,000 |
Other | $22,000 |
Total | $2,175,253 |
Lowrance received $1.7M in option awards, accounting for 77% of the total pay in 2018.
Lowrance also received $116.9K in non-equity incentive plan, $365K in salary and $22K in other compensation.
Rankings
In 2018, Dave Lowrance's compensation ranked 5,291st out of 14,244 executives tracked by ExecPay. In other words, Lowrance earned more than 62.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,291 | 63rd |
Manufacturing | 1,998 | 65th |
Chemicals And Allied Products | 730 | 66th |
Drugs | 610 | 66th |
Pharmaceutical Preparations | 470 | 66th |
Pay ratio
Dave Lowrance's Pay | $2,175,253 |
---|---|
Median Employee's Pay | $282,179 |
Pay Ratio | 8to 1 |
In 2018, the annual total compensation of Dave Lowrance was $2,175,253.
The annual total compensation of the median employee at Mast Therapeutics was $282,179.
The ratio of Dave Lowrance's pay to the pay of median employee was therefore 8 to one.
Lowrance's colleagues
We found three more compensation records of executives who worked with Dave Lowrance at Mast Therapeutics in 2018.